Levamisole Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg & 150 mg
Reference Brands: Generic formulations
Category: Anthelmintic
Levamisole enhances immune response by stimulating T-cell activity and modulating immune function. It also has anthelmintic properties, targeting parasitic worms. Benefits include effective treatment of intestinal parasites, immune support in certain diseases, and potential cancer therapy adjuncts. It supports parasite eradication and immune modulation worldwide. Levamisole tablets is available in Tablets and strengths such as 50 mg & 150 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Levamisole tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Levamisole tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Levamisole tablets are approved primarily in Europe for parasitic infections and immune modulation, with limited regulatory approval in the US. Regulatory dossiers must include clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. In the US, the FDA reviews quality and safety data, while the EU’s EMA oversees regional safety and quality compliance. For guidance on dossier preparation, regulatory pathways, and market entry, visit PharmaTradz. Proper adherence to regional requirements supports timely approval, safe use, and global availability, ensuring effective treatment of parasitic infections and immune-related conditions worldwide, with a focus on safety and efficacy.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Levamisole is used for treating intestinal worm infections such as ascariasis. It has also been used as an immunomodulatory agent in certain autoimmune conditions, although this use is limited today due to safety concerns. Its primary role remains as an anthelmintic for roundworm infections.
Levamisole is made from the active pharmaceutical ingredient levamisole hydrochloride, a synthetic imidazothiazole derivative with anthelmintic and immune-modulating activity.
A well-known trade name for Levamisole is Decaris.
Decaris was originally manufactured by Janssen Pharmaceuticals. Many generic manufacturers in India, Europe, and other regions also produce levamisole hydrochloride.
The generic name is levamisole hydrochloride.
A commonly known brand name is Decaris.
Levamisole is manufactured in several countries including India, China, and various European regions, where both branded and generic versions are produced.
Related Products
Mefloquine Hydrochloride
Strength:
250 mg
Form: Tablets
Reference Brands: Lariam (USA/EU)
View Details
Diethylcarbamazine (Dec) Tablet
Strength:
100 mg
Form: Tablets
Reference Brands: Generic formulations available in various generic brands
View Details
Praziquantel Tablets
Strength:
600 mg
Form: Tablets
Reference Brands: Biltricide(US & EU)
View DetailsQuick Response Guaranteed | Verified Suppliers
